Stock Analysis

Euronext Paris Growth Companies With High Insider Ownership For August 2024

Published

As hopes for a soft landing grow in the U.S., European markets, including France, have shown strong gains, with the CAC 40 Index advancing by 2.48%. In this favorable market environment, growth companies with high insider ownership can be particularly attractive due to their potential for robust performance and alignment of interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In France

NameInsider OwnershipEarnings Growth
Groupe OKwind Société anonyme (ENXTPA:ALOKW)24.8%36%
VusionGroup (ENXTPA:VU)13.4%25.7%
Adocia (ENXTPA:ADOC)11.9%63%
Icape Holding (ENXTPA:ALICA)30.2%35.1%
Arcure (ENXTPA:ALCUR)21.4%27.5%
La Française de l'Energie (ENXTPA:FDE)19.9%31.9%
S.M.A.I.O (ENXTPA:ALSMA)17.4%35.2%
Munic (ENXTPA:ALMUN)29.2%149.2%
MedinCell (ENXTPA:MEDCL)15.8%93.9%
OSE Immunotherapeutics (ENXTPA:OSE)25.6%5.9%

Click here to see the full list of 23 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Lectra (ENXTPA:LSS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, and furniture markets across Northern and Southern Europe, the Americas, and the Asia Pacific with a market cap of €1.03 billion.

Operations: The company's revenue segments are as follows: €172.65 million from the Americas and €118.54 million from the Asia Pacific, with a segment adjustment of €209.13 million.

Insider Ownership: 19.6%

Revenue Growth Forecast: 10.4% p.a.

Lectra, a French growth company with high insider ownership, reported half-year sales of €262.29 million, up from €239.55 million last year, though net income decreased to €12.51 million from €14.47 million. Despite this dip in profitability, analysts expect Lectra's revenue to grow at 10.4% annually and earnings at 29.3%, both outpacing the French market averages of 5.8% and 12.2%, respectively, suggesting strong future potential despite current challenges.

ENXTPA:LSS Earnings and Revenue Growth as at Aug 2024

MedinCell (ENXTPA:MEDCL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A., with a market cap of €527.07 million, is a pharmaceutical company in France that develops long-acting injectables across various therapeutic areas.

Operations: MedinCell generates its revenue primarily from the pharmaceuticals segment, amounting to €11.95 million.

Insider Ownership: 15.8%

Revenue Growth Forecast: 45.9% p.a.

MedinCell is forecast to become profitable within the next three years, with revenue expected to grow 45.9% annually, significantly outpacing the French market's 5.8%. Trading at 86.8% below its estimated fair value, analysts predict a stock price increase of 21.6%. Despite a net loss of €25.04 million for the year ending March 31, 2024, this marks an improvement from the previous year's €32.01 million loss, indicating potential for future growth.

ENXTPA:MEDCL Ownership Breakdown as at Aug 2024

Eurazeo (ENXTPA:RF)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Eurazeo SE is a private equity and venture capital firm that focuses on growth capital, acquisitions, leveraged buyouts, and investments in mid-market and listed public companies, with a market cap of €5.14 billion.

Operations: The firm's revenue segments include growth capital, acquisitions, leveraged buyouts, and investments in mid-market and listed public companies.

Insider Ownership: 12.1%

Revenue Growth Forecast: 47.4% p.a.

Eurazeo SE, a growth company with high insider ownership in France, reported half-year sales of €180.71 million but faced a net loss of €104.56 million compared to last year's net income of €1.80 billion. Despite this, the company completed a share buyback worth €109 million and is trading significantly below its estimated fair value. Revenue is forecast to grow 47.4% annually, outpacing the market's 5.8%, with analysts expecting profitability within three years and a potential stock price rise of 29.7%.

ENXTPA:RF Ownership Breakdown as at Aug 2024

Where To Now?

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com